University of Manchester

What University of Manchester does

The University of Manchester is a public research university formed in 2004 through the merger of the Victoria University of Manchester and UMIST, operating under a Royal Charter and tracing its heritage to Owens College (1851) and the Manchester Mechanics' Institute (1824). It serves over 65,000 students and staff across its Oxford Road campus and off-campus facilities including the National Graphene Institute, Cancer Research UK Manchester Institute, Dalton Cumbrian Facility, Jodrell Bank Discovery Centre, and the Manchester Cancer Research Centre. The institution is organized around five research beacons (advanced materials, biotechnology, cancer, energy, and global inequalities) and runs research collaborations with CERN, IBM, Microsoft, Imperial, Cambridge, Oxford, and the UK National Nuclear Laboratory.

The university's technology stack spans fundamental and applied research infrastructure: specialised platforms in 2D materials (graphene), atomic-scale nanomachines under a €3.4m ERC Advanced Grant (ATOMSTEP), AI diagnostic tools (Ret-AAE on UK Biobank data), robotics for low-light environments, gene therapy (world-first Hunter syndrome treatment in February 2025), graphene-based brain-computer interfaces (first-in-human trial), nuclear concrete remediation research, and quantum chemistry (first half-Möbius C13Cl2 molecule with IBM Research, published in Science March 2026). Data infrastructure generates up to 15TB of research data daily across 3.5 billion files.

Its business model combines tiered tuition fees (UK ~£9,250/year regulated, international £20k–£30k+), research grants and contracts from UKRI and charities (e.g., British Heart Foundation, Cancer Research UK, EPSRC, ARIA, LifeArc), philanthropy through the "Challenge Accepted" campaign, and spinout commercialization/licensing. Student recruitment operates direct-to-consumer via open days, UCAS, clearing, and international fairs across 160+ countries, complemented by partnership-driven channels in Cyprus (Frederick University medical school) and India/Southeast Asia. The institution is governed by a Board of Trustees chaired under the presidency of Professor Duncan Ivison and is not listed on any stock exchange.

Name

University of Manchester

Legal name

The University of Manchester

Website

https://manchester.ac.uk

Company type

Public

Founded year

2004

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

The University of Manchester is a UK public research university serving 65,000 students and staff across five research beacons (advanced materials, biotechnology, cancer, energy, global inequalities), generating revenue through tuition, UKRI research grants, philanthropy, and spinout commercialization.

Ownership category

akta.pro rank

Product category

Higher Education and Research

NAICS

Colleges, Universities, and Professional Schools (611310), Colleges, Universities, and Professional Schools (6113), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in Nanotechnology (541713)

SIC

Services-Educational Services (8200), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Technology Transfer & Innovation-Driven Research Universities (High Commercialization) (EDAHABAH)

akta.pro secondary industries

Flagship Public Research Universities (R1/R2) (EDAHAAAA), Public Research Universities with Comprehensive Graduate & Professional Schools (EDAHAAAF), Applied Research & Innovation Universities (EDAHAEAE)

Keywords

• Higher education programs
• University research services
• Postgraduate taught degrees
• Professional development courses
• Research commercialization

Headquarters

HQ city

Manchester

HQ country

United Kingdom

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Tuition Fees: Revenue from undergraduate, postgraduate taught, and postgraduate research programs across domestic and international student populations. The university charges tiered fees based on student domicile status and program level.
2. Research Grants and Contracts: Substantial funding from UK Research and Innovation (UKRI), Research Councils, charities including Cancer Research UK, and international funding bodies for research projects across all disciplines.
3. Philanthropy and Fundraising: Global fundraising and volunteering campaign 'Challenge Accepted' raising funds for student inclusion, research, innovation, and culture initiatives in partnership with British High Commission.
4. Spinout Companies and Commercialization: Revenue from commercializing research through spinout companies and licensing of intellectual property developed at the university.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels7 records

Core offering

The University of Manchester is a public research university that delivers higher education degree programs (undergraduate, taught master's, postgraduate research, postgraduate certificates/diplomas) alongside online and blended learning, continuing professional development courses, and large-scale research collaborations. It also engages in technology commercialization through spinout companies, IP licensing, and industry partnerships spanning advanced materials, biotechnology, cancer, energy, and global inequalities.

Product overview

The University of Manchester is a higher education institution offering undergraduate, master's, and postgraduate research programs across multiple disciplines. The institution does not offer commercial technology products or SaaS offerings. Its core products are educational programs, research collaborations, and academic services. The university operates research platforms including the Research Explorer portal for publications and projects, and maintains partnerships with technology providers (Microsoft 365 Copilot) for internal use. No commercial product portfolio exists for external customers.

Differentiator

Problem solved

Functional benefit

Brands

• Unit M: A deep-tech accelerator program providing £25,000 equity-free funding to 10 climate, AI, and biotech startups.

Products and services

• Undergraduate Degree Programs Three- to four-year undergraduate degree programs across all major disciplines including arts, sciences, engineering, business, and medicine, primarily for school-leaver applicants aged 17-19. UK undergraduate tuition is regulated by the UK government at approximately £9,250 per year; international students pay premium tuition.
• Taught Master's Degree Programs One-year taught postgraduate master's degree programs for graduates seeking subject specialization or career advancement, available across multiple disciplines with admissions processed directly through the university portal.
• Postgraduate Research Degree Programs (PhD and Professional Doctorates) Three- to four-year PhD and professional doctorate research degree programs for candidates pursuing research careers. Funded PhD students receive a tax-free stipend of approximately £1,800 per month, with research conducted under faculty supervision across the university's research beacons.
• Postgraduate Certificates and Diplomas Shorter-format postgraduate certificate and diploma programs for professionals seeking credentials in specialized fields without committing to a full master's degree, typically completed over several months.
• Online and Blended Learning Programs Distance and continuing education programs delivered online or through blended formats, enabling students to access University of Manchester qualifications remotely without on-campus residency.
• Continuing Professional Development (CPD) Courses Short-format professional development courses designed for working professionals seeking to update skills, earn credentials, or pivot careers, available through direct university enrollment across multiple disciplines.
• Research Collaboration and Contract Research Services Contract research and consulting services delivered to industry, government agencies, and charities across the university's five research beacons (advanced materials, biotechnology, cancer, energy, global inequalities), funded by UK Research and Innovation (UKRI), Research Councils, Cancer Research UK, and international bodies.
• Unit M Deep-Tech Accelerator Program Deep-tech accelerator program providing £25,000 equity-free funding to 10 startups working on climate, AI, and biotech innovations, with access to University of Manchester research expertise, facilities, and commercialization support.
• Spinout Companies and Intellectual Property Licensing Technology commercialization pathway offering intellectual property licensing and spinout company formation support for research outputs developed at the University of Manchester, generating licensing royalties and equity stakes.

Quantifiable outcome

• Ranked 40th globally in QS World University Rankings 2027 with score of 84.6
• +4 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

27 partnerships are on record, tiered core and minor.

• Frederick University (Cyprus)coreStrategic or Co-development Partner · 24 June 2026Cyprus is establishing a British Council-style organization to boost international student recruitment. President highlighted Frederick University's new medical school partnership with University of Manchester as part of the sector's continuous development path. Higher education contributes approximately 7-8% of Cyprus's GDP.
• MicrosoftcoreStrategic or Co-development Partner · 19 January 2026World-first partnership to provide Microsoft 365 Copilot access and training to all 65,000 students and staff. Rollout targeted for completion by summer 2026. Pilot showed 90% adoption within 30 days. Part of broader digital and AI transformation program focused on AI literacy and equity.
• PETRONAScoreStrategic or Co-development PartnerPart of international team awarded Royal Society of Chemistry Horizon Prize for solid-state battery technology. Team received Stephanie L Kwolek Prize for developing scalable solid-state lithium metal battery architecture using nanocarbon-enhanced cathodes with solid electrolytes, focusing on commercialization barriers.
• Deakin UniversitycoreStrategic or Co-development PartnerCollaboration on solid-state battery technology as part of international team awarded RSC Horizon Prize. Focus on overcoming energy density, safety, and manufacturability barriers for commercialization.
• DatadobicoreTechnology or IntegrationUniversity using StorageMAP software to scan and analyze 3.5 billion files to identify old and under-accessed data for archival storage. Deployment enables moving data to tape-based cold storage platform, avoiding expensive primary storage expansion from 10PB to 20PB.
• Inbrain NeuroelectronicscoreStrategic or Co-development PartnerFirst-in-human study evaluating graphene-based cortical interfaces during brain tumor resection surgeries. Trial completed enrollment of 10 patients with 8 treated surgically, demonstrating favorable safety profile and high-resolution neural signal detection.
• AngioDynamicscoreStrategic or Co-development PartnerLaunching LIVER-IRE Global Registry to assess outcomes in patients receiving irreversible electroporation (IRE) treatment for liver tumors. Builds on October 2024 collaboration with UCL Hospital for prostate cancer registry.
• IBM ResearchcoreStrategic or Co-development PartnerCollaboration creating first-ever half-Möbius molecule (C13Cl2). Published in Science, March 2026. Molecule twists only 90° per circumnavigation vs 180° for regular Möbius aromatics. Validated using IBM quantum computing within quantum-centric supercomputing workflow.
• UK National Nuclear LaboratorycoreStrategic or Co-development PartnerCollaboration on research finding that crushed concrete from nuclear facilities can actively remove strontium-90 from groundwater. Funded by Nuclear Decommissioning Authority, supporting decisions about on-site disposal at Sellafield and Hanford.
• Clemson UniversitycoreStrategic or Co-development PartnerResearch collaboration with University of Manchester and UK National Nuclear Laboratory on nuclear concrete remediation, funded by Nuclear Decommissioning Authority.
• Northern Care Alliance NHS Foundation TrustcoreStrategic or Co-development PartnerTrial conducted with Northern Care Alliance NHS Foundation Trust for first-in-human brain-computer interface study using graphene cortical interface technology.
• Poolbeg PharmaminorStrategic or Co-development PartnerUniversity provided preclinical evidence that Poolbeg's POLB 001 drug candidate may enhance efficacy of azacitidine in aged mouse models of acute myeloid leukemia, presented at EHA Congress.
• C-MET (India)coreStrategic or Co-development PartnerJoint organizer of GraphIN 2026 international graphene conference in Kochi, India, together with PHANTOM Foundation (Spain). Nobel laureate Prof Kostya Novoselov inaugurated the event.
• PHANTOM Foundation (Spain)coreStrategic or Co-development PartnerJoint organizer with C-MET (India) and University of Manchester of GraphIN 2026 international graphene conference, first edition bringing together scientists, innovators, and industry from across the world.
• University of CambridgecoreStrategic or Co-development PartnerCambridge x Manchester cross-city innovation collaboration launched with inaugural meetings in Manchester. Partnership Director Faye Holland appointed. Secured £4.8m in UKRI Research England funding over three years plus additional investment from both universities.
• India Semiconductor MissionminorStrategic or Co-development PartnerConference highlighted India's Semiconductor Mission with ten manufacturing proposals worth approximately Rs 1.6 lakh crore approved, supporting over 100 start-ups and MSMEs under Design Linked Incentive scheme.
• Durham UniversitycoreStrategic or Co-development PartnerManchester researchers part of £7 million EPSRC-funded MoSS (Molecular Solid Solutions) project led by Durham University, developing new methods for designing molecular crystals for medicines, agrochemicals, foods, and electronics.
• University of LeedscoreStrategic or Co-development PartnerPart of £7 million MoSS research project on molecular crystal design alongside Durham and Manchester universities, funded by EPSRC for five-and-a-half years.
• CERNcoreStrategic or Co-development PartnerScientists led by University of Manchester discovered new heavy particle Ξcc⁺ using upgraded LHCb detector, the 80th particle found by LHCb and confirmation of doubly-charmed particle at approximately 3620 MeV/c².
• Nuclear Decommissioning Authority (NDA)coreStrategic or Co-development PartnerCollaboration through RAICo (with UK Atomic Energy Authority, Atomic Weapons Establishment, and University of Manchester) driving innovation in nuclear decommissioning through robotics, AI, and advanced materials.
• IIT GuwahaticoreStrategic or Co-development PartnerCollaboration with London South Bank University, University of Manchester, and University of Leeds developing machine learning-assisted framework to design advanced metal alloys without Critical Raw Materials.
• London South Bank UniversitycoreStrategic or Co-development PartnerPart of multi-university collaboration developing AI-based metal alloy design framework avoiding Critical Raw Materials for aerospace, nuclear, automotive, and industrial machinery applications.
• University of LeedscoreStrategic or Co-development PartnerCollaboration on machine learning-assisted alloy design framework alongside IIT Guwahati, London South Bank, and Manchester universities.
• Imperial College LondoncoreStrategic or Co-development PartnerCollaboration published in Nature Materials observing iridium oxide catalysts in proton exchange membrane electrolysers under real operating conditions, potentially improving green hydrogen production efficiency.
• University of OxfordcoreStrategic or Co-development PartnerPart of multi-institution research on green hydrogen production catalysts with Imperial, Manchester, University of Copenhagen, and Diamond Light Source, funded by bp-International Centre for Advanced Materials.
• Diamond Light SourcecoreStrategic or Co-development PartnerCollaborating on iridium oxide catalyst research for green hydrogen production, using Diamond's synchrotron facilities for real-time observation of catalyst behavior.
• EU Horizon Europe ProjectsminorStrategic or Co-development PartnerPart of ROADVIEW, NimbleAI, and ETERNAL EU-funded research projects enabled by UK's rejoining of Horizon Europe on January 1, 2024, addressing automated driving, neuromorphic computing, and sustainable pharmaceuticals.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Imperial College London: STEM-focused Russell Group research university with comparable research intensity and similar funding mix (UKRI, industry, international tuition). Co-collaborator with Manchester on iridium-oxide catalyst research for green hydrogen.
• University of Oxford: Top-tier UK research university and fellow Russell Group member with similar income scale, Nobel laureate count, and global ranking tier. Direct competitor for international students, research grants, and spinout formation.
• King's College London: London-based Russell Group research university with strong medical sciences, comparable research scale, and similar reliance on international tuition. Direct competitor in the Russell Group admissions market.
• University of Edinburgh: Large UK Russell Group research university with comparable income scale and research breadth across STEM, humanities, and medicine. Direct competitor for international postgraduate students and UKRI grant capture.
• University of Cambridge: Direct Russell Group peer of comparable scale and research intensity. The two universities have just launched the Cambridge x Manchester cross-city innovation partnership, explicitly positioning them as co-equals in UK research leadership.
• University College London (UCL): London-based Russell Group research university of similar scale and research breadth. Active research and clinical partner (UCL Hospital collaboration on NanoKnife IRE prostate cancer registry).
• University of Bristol: Mid-size Russell Group research university with comparable research intensity and STEM strengths. Competes directly with Manchester for UK undergraduate clearing, postgraduate research students, and UKRI grants.
• University of Warwick: Russell Group research university with strong research and commercialization focus (Warwick Ventures). Comparable in size and a direct competitor for UK undergraduates, postgraduate research students, and applied research funding.
• University of Leeds: Russell Group research university of similar scale and Northern England positioning. Active research partner on the MoSS molecular crystal design project and on machine-learning alloy design alongside Manchester.

Emerging players

• ETH Zurich: Top-tier European STEM-focused research university with comparable research intensity, Nobel tradition, and deep-tech commercialization model. Useful international benchmark for European research-university positioning and global student recruitment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/OfficialUoM
• YouTubeyoutube.com/universitymanchester
• Facebookfacebook.com/TheUniversityOfManchester
• LinkedInlinkedin.com/company/the-university-of-manchester-12671
• Instagraminstagram.com/officialuom
• TikToktiktok.com/@officialuom

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds7 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University of Manchester